H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 322,570. Kentucky Medicare wound biologics: CGS Administrators (J15). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Lexington clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Lexington storefront.
Skin Substitute Therapy Products in Lexington, KY for clinics & physicians. Skin substitute therapy for co… Compliance support & pricing — contact Hawk Medical.
Two files matter before you open a box of skin substitute therapy in Lexington: (1) CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. (2) Kentucky Part B wound biologics are reviewed by CGS Administrators under J15, shared with OH. We help with the second file. We do not pretend to be a Lexington storefront.
National Skin Substitute Therapy Products notes (how the product actually works)Kentucky shares J15 with OH. Florida is the only single-state MAC. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. If you also operate in another contractor’s state, say so on the first call — we map both.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES does not publish a city-level diabetes row for Lexington. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the skin substitute therapy account.
CDC PLACES has no incorporated-place row we could match for Lexington. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Kentucky compliance risk.
Body copy and schema dateModified follow a pinned content version date, not a daily timestamp. CDC and CMS figures are cited to the public reports named on the page. Recheck MAC LCDs before each utilization change — those move faster than a landing page.
Joe Bradley, Founder & CEO of Hawk Medical LLC, is an active clinical practice owner. These programmatic pages are distribution resources for providers, reviewed against the same HCT/P and wound-care portfolio used in that practice. They are not patient treatment advice.
Bring specialty, monthly wound volume, and whether you bill J15 FFS, Advantage, workers’ comp, or cash-pay. PLACES has no city row here; bring your own panel mix. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Lexington, KY.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Lexington is J15 geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Kentucky Part B wound biologics follow this contractor (siblings: OH). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 250k–500k, not a count of orthopedic groups.
No Lexington storefront. Joe Bradley is an active practice owner. skin substitute therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.